Literature DB >> 20067548

Investigation of esophageal sensation and biomechanical properties in functional chest pain.

I Nasr1, A Attaluri, S Hashmi, H Gregersen, S S C Rao.   

Abstract

BACKGROUND: There is limited and conflicting data regarding the role of esophageal hypersensitivity in the pathogenesis of functional chest pain (FCP). We examined esophageal sensori-motor properties, mechanics, and symptoms in subjects with FCP.
METHODS: Esophageal balloon distension test was performed using impedance planimetry in 189 (m/f = 57/132) consecutive subjects with non-cardiac, non-reflux chest pain, and 36 (m/f = 16/20) healthy controls. The biomechanical and sensory properties of subjects with and without esophageal hypersensitivity were compared with controls. The frequency, intensity, and duration of chest pain were assessed. KEY
RESULTS: One hundred and forty-three (75%) subjects had esophageal hypersensitivity and 46 (25%) had normal sensitivity. Typical chest pain was reproduced in 105/143 (74%) subjects. Subjects with hypersensitivity demonstrated larger cross-sectional area (P < 0.001), decreased esophageal wall strain (P < 0.001) and distensibility (P < 0.001), and lower thresholds for perception (P < 0.01), discomfort (P < 0.01), and pain (P < 0.01) compared to those without hypersensitivity or healthy controls. Chest pain scores (mean +/- SD) for frequency, intensity and duration were 2.5 +/- 0.3, 2.2 +/- 0.2, and 2.2 +/- 0.2, respectively, and were similar between the two patient groups. CONCLUSIONS & INFERENCES: Seventy-five per cent of subjects with FCP demonstrate esophageal hypersensitivity. Visceral hyperalgesia and sensori-motor dysfunction of the esophagus play a key role in the pathogenesis of chest pain.

Entities:  

Mesh:

Year:  2010        PMID: 20067548      PMCID: PMC2949059          DOI: 10.1111/j.1365-2982.2009.01451.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  49 in total

1.  Pharmacodynamic interactions between infused adenosine and oral theophylline.

Authors:  N A Minton; J A Henry
Journal:  Hum Exp Toxicol       Date:  1991-11       Impact factor: 2.903

Review 2.  Impedance planimetry: a new approach to biomechanical intestinal wall properties.

Authors:  H Gregersen; J C Djurhuus
Journal:  Dig Dis       Date:  1991       Impact factor: 2.404

Review 3.  Visceral nociceptors: a new world order?

Authors:  F Cervero; W Jänig
Journal:  Trends Neurosci       Date:  1992-10       Impact factor: 13.837

4.  Intraesophageal balloon distention versus drug provocation in the evaluation of noncardiac chest pain.

Authors:  W K Deschner; K A Maher; E L Cattau; S B Benjamin
Journal:  Am J Gastroenterol       Date:  1990-08       Impact factor: 10.864

5.  Unexplained chest pain: the hypersensitive, hyperreactive, and poorly compliant esophagus.

Authors:  S S Rao; H Gregersen; B Hayek; R W Summers; J Christensen
Journal:  Ann Intern Med       Date:  1996-06-01       Impact factor: 25.391

6.  Biomechanical characteristics of the human esophagus.

Authors:  K B Orvar; H Gregersen; J Christensen
Journal:  Dig Dis Sci       Date:  1993-02       Impact factor: 3.199

7.  Intraesophageal balloon distention in the evaluation of sensory thresholds: studies on reproducibility and comparison of balloon composition.

Authors:  H Lasch; K R DeVault; D O Castell
Journal:  Am J Gastroenterol       Date:  1994-08       Impact factor: 10.864

8.  Impedance planimetry: an integrated approach for assessing sensory, active, and passive biomechanical properties of the human esophagus.

Authors:  S S Rao; B Hayek; R W Summers
Journal:  Am J Gastroenterol       Date:  1995-03       Impact factor: 10.864

Review 9.  Basic and clinical aspects of visceral hyperalgesia.

Authors:  E A Mayer; G F Gebhart
Journal:  Gastroenterology       Date:  1994-07       Impact factor: 22.682

10.  Functional chest pain: esophageal or overlapping functional disorder.

Authors:  Ranjit S Mudipalli; Jose M Remes-Troche; Leslie Andersen; Satish S C Rao
Journal:  J Clin Gastroenterol       Date:  2007-03       Impact factor: 3.062

View more
  20 in total

1.  Barostat or dynamic balloon distention test: which technique is best suited for esophageal sensory testing?

Authors:  J M Remes-Troche; A Attaluri; P Chahal; S S C Rao
Journal:  Dis Esophagus       Date:  2011-12-13       Impact factor: 3.429

2.  Mechanisms of the adenosine A2A receptor-induced sensitization of esophageal C fibers.

Authors:  M Brozmanova; L Mazurova; F Ru; M Tatar; Y Hu; S Yu; M Kollarik
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-11-12       Impact factor: 4.052

3.  Hypnotherapy for Esophageal Disorders.

Authors:  Megan E Riehl; Laurie Keefer
Journal:  Am J Clin Hypn       Date:  2015-07

4.  Diagnosis and management of esophageal chest pain.

Authors:  Satish S C Rao
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-01

Review 5.  The role of oesophageal physiological testing in the assessment of noncardiac chest pain.

Authors:  Henriette Heinrich; Rami Sweis
Journal:  Ther Adv Chronic Dis       Date:  2018-09-11       Impact factor: 5.091

6.  Feasibility and acceptability of esophageal-directed hypnotherapy for functional heartburn.

Authors:  M E Riehl; J E Pandolfino; O S Palsson; L Keefer
Journal:  Dis Esophagus       Date:  2015-03-30       Impact factor: 3.429

7.  Temporal and spectral properties of esophageal mucosal blood perfusion: a comparison between normal subjects and nutcracker esophagus patients.

Authors:  A Zifan; Y Jiang; R K Mittal
Journal:  Neurogastroenterol Motil       Date:  2016-08-10       Impact factor: 3.598

Review 8.  How to Diagnose and Treat Functional Chest Pain.

Authors:  Jose M Remes-Troche
Journal:  Curr Treat Options Gastroenterol       Date:  2016-12

9.  Exertional esophageal pH-metry and manometry in recurrent chest pain.

Authors:  Jacek Budzyński
Journal:  World J Gastroenterol       Date:  2010-09-14       Impact factor: 5.742

10.  Noncardiac chest pain: epidemiology, natural course and pathogenesis.

Authors:  Ronnie Fass; Sami R Achem
Journal:  J Neurogastroenterol Motil       Date:  2011-04-27       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.